Adverse Events : Race, Inequality, and the Testing of New Pharmaceuticals /
Explores the social inequality of clinical drug testing and its effects on scientific resultsImagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a r...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, NY :
New York University Press,
[2020]
|
Colección: | Anthropologies of American Medicine: Culture, Power, and Practice ;
9 |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
MARC
LEADER | 00000nam a22000005i 4500 | ||
---|---|---|---|
001 | DEGRUYTERUP_9781479861439 | ||
003 | DE-B1597 | ||
005 | 20230127011820.0 | ||
006 | m|||||o||d|||||||| | ||
007 | cr || |||||||| | ||
008 | 230127t20202020nyu fo d z eng d | ||
010 | |a 2019723468 | ||
020 | |a 9781479861439 | ||
024 | 7 | |a 10.18574/nyu/9781479877997.001.0001 |2 doi | |
035 | |a (DE-B1597)550505 | ||
035 | |a (OCoLC)1165364935 | ||
040 | |a DE-B1597 |b eng |c DE-B1597 |e rda | ||
041 | 0 | |a eng | |
044 | |a nyu |c US-NY | ||
050 | 0 | 0 | |a RM301.27 |
050 | 4 | |a RM301.27 |b .F56 2021 | |
072 | 7 | |a SOC002000 |2 bisacsh | |
082 | 0 | 4 | |a 615.10973 |2 23 |
100 | 1 | |a Fisher, Jill A., |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
245 | 1 | 0 | |a Adverse Events : |b Race, Inequality, and the Testing of New Pharmaceuticals / |c Jill A. Fisher. |
264 | 1 | |a New York, NY : |b New York University Press, |c [2020] | |
264 | 4 | |c ©2020 | |
300 | |a 1 online resource : |b 9 black and white illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file |b PDF |2 rda | ||
490 | 0 | |a Anthropologies of American Medicine: Culture, Power, and Practice ; |v 9 | |
505 | 0 | 0 | |t Frontmatter -- |t Contents -- |t List of Tables and Figures -- |t Introduction: "Your Health Is Your Wealth" -- |t 1. Entering the Clinic -- |t 2. "Doing the Lab Rat Thing" -- |t 3. A Tale of Three Cultures -- |t 4. The Commercialization of Phase I Trials -- |t 5. A Laboratory for Human Animals -- |t 6. The Dark Side of the Model -- |t 7. Consenting to Adverse Events -- |t 8. Constructing Risk Knowledge -- |t 9. Speculating on Health -- |t Conclusion: The Social Inequality of Adverse Events -- |t Acknowledgments -- |t Notes -- |t Bibliography -- |t Index -- |t About the Author |
506 | 0 | |a restricted access |u http://purl.org/coar/access_right/c_16ec |f online access with authorization |2 star | |
520 | |a Explores the social inequality of clinical drug testing and its effects on scientific resultsImagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. | ||
538 | |a Mode of access: Internet via World Wide Web. | ||
546 | |a In English. | ||
588 | 0 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 27. Jan 2023) | |
650 | 0 | |a Drugs |x Testing |x Social aspects |z United States. | |
650 | 0 | |a Equality |x Health aspects |z United States. | |
650 | 0 | |a Human experimentation in medicine |x Moral and ethical aspects |z United States. | |
650 | 0 | |a Racism in medicine |z United States. | |
650 | 7 | |a SOCIAL SCIENCE / Anthropology / General. |2 bisacsh | |
653 | |a United States. | ||
653 | |a clinic. | ||
653 | |a clinical trial culture. | ||
653 | |a clinical trials. | ||
653 | |a clinics. | ||
653 | |a confinement. | ||
653 | |a consumption. | ||
653 | |a decision making. | ||
653 | |a demographics. | ||
653 | |a drug development. | ||
653 | |a economic interests. | ||
653 | |a economic motivations. | ||
653 | |a economic need. | ||
653 | |a economic risk. | ||
653 | |a epistemology. | ||
653 | |a health-promoting behavior. | ||
653 | |a healthy volunteers. | ||
653 | |a identity. | ||
653 | |a imbricated stigma. | ||
653 | |a inclusion-exclusion criteria. | ||
653 | |a informed consent. | ||
653 | |a methods. | ||
653 | |a model organism. | ||
653 | |a opportunism. | ||
653 | |a participation. | ||
653 | |a pharmaceutical industry. | ||
653 | |a phase I clinical trials. | ||
653 | |a phase I industry. | ||
653 | |a phase I trials. | ||
653 | |a phase I. | ||
653 | |a profit. | ||
653 | |a public health. | ||
653 | |a qualifying. | ||
653 | |a race. | ||
653 | |a region. | ||
653 | |a reputation. | ||
653 | |a research participation. | ||
653 | |a research staff. | ||
653 | |a risk. | ||
653 | |a screen failure. | ||
653 | |a serial participation. | ||
653 | |a social inequalities. | ||
653 | |a social inequality. | ||
653 | |a social network. | ||
653 | |a social world. | ||
653 | |a study compensation. | ||
653 | |a validity. | ||
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t EBOOK PACKAGE COMPLETE 2020 English |z 9783110704716 |
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t EBOOK PACKAGE COMPLETE 2020 |z 9783110704518 |o ZDB-23-DGG |
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t EBOOK PACKAGE Social Sciences 2020 English |z 9783110704723 |
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t EBOOK PACKAGE Sociology, Education, Psychology 2020 |z 9783110704549 |o ZDB-23-SEW |
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t New York University Press Complete eBook-Package 2020 |z 9783110722703 |
776 | 0 | |c print |z 9781479877997 | |
856 | 4 | 0 | |u https://doi.uam.elogim.com/10.18574/nyu/9781479877997.001.0001 |z Texto completo |
856 | 4 | 0 | |u https://degruyter.uam.elogim.com/isbn/9781479861439 |z Texto completo |
912 | |a 978-3-11-070471-6 EBOOK PACKAGE COMPLETE 2020 English |b 2020 | ||
912 | |a 978-3-11-070472-3 EBOOK PACKAGE Social Sciences 2020 English |b 2020 | ||
912 | |a 978-3-11-072270-3 New York University Press Complete eBook-Package 2020 |b 2020 | ||
912 | |a EBA_BACKALL | ||
912 | |a EBA_CL_SN | ||
912 | |a EBA_EBACKALL | ||
912 | |a EBA_EBKALL | ||
912 | |a EBA_ECL_SN | ||
912 | |a EBA_EEBKALL | ||
912 | |a EBA_ESSHALL | ||
912 | |a EBA_PPALL | ||
912 | |a EBA_SSHALL | ||
912 | |a GBV-deGruyter-alles | ||
912 | |a PDA11SSHE | ||
912 | |a PDA13ENGE | ||
912 | |a PDA17SSHEE | ||
912 | |a PDA5EBK | ||
912 | |a ZDB-23-DGG |b 2020 | ||
912 | |a ZDB-23-SEW |b 2020 |